Navigation Links
New study calculates millions of years saved in lives of AIDS patients

This year, the U.S. federal government will spend $21 billion for HIV/AIDS research, treatment, prevention, and related activities. Is this enormous expenditure paying off? A study published in the July 1 issue of The Journal of Infectious Diseases, now available online, indicates that it is--and more so than previously thought.

The study, by Rochelle P. Walensky, MD, MPH, Kenneth Freedberg , MD, MSc and colleagues at Massachusetts General Hospital and other centers appears at a time the world contemplates the 25-year anniversary of the first reported cases of AIDS and celebrates the 10-year anniversary of the use of multi-drug antiretroviral combinations for the treatment of HIV infections (also known as highly active antiretroviral therapy or HAART).

To analyze the impact of HAART on patient survival, the investigators used a computer simulation model to examine national surveillance and efficacy data for newly diagnosed adult AIDS patients under care in the United States from 1989 to 2003. They divided those years into "eras" corresponding to specific advances in AIDS care, and then used the simulation model to determine per-person survival time for each era, compared to the absence of treatment.

The results: Per-person survival increased by three months in 1989-92 and then by two years in 1993-95; both eras were characterized by the introduction of certain measures to prevent opportunistic infections. But in the four HAART eras spanning 1996 to 2003, per-person survival increased by approximately eight, 11, 12, and 13 years. Over the past 10 years, the investigators concluded, widespread adoption of HAART regimens, in addition to prophylaxis, led to at least 3 million years of life saved in the United States. Moreover, since approximately 25 percent of those infected with HIV in the United States are estimated to be unaware of their infection and little more than half of those who are aware of it are actually in care, Dr. Walensky and cow
'"/>

Source:Infectious Diseases Society of America


Page: 1 2

Related biology news :

1. Bioartificial kidney under study at MCG
2. W.M. Keck Foundation funds study of friendly microbes
3. Yellowstone microbes fueled by hydrogen, according to U. of Colorado study
4. Genome-wide mouse study yields link to human leukemia
5. Clam embryo study shows pollutant mixture adversely affects nerve cell development
6. New imaging method gives early indication if brain cancer therapy is effective, U-M study shows
7. Same mutation aided evolution in many fish species, Stanford study finds
8. Sequencing of marine bacterium will help study of cell communication
9. Genetically modified rice in China benefits farmers health, study finds
10. A new study examines how shared pathogens affect host populations
11. NYU study reveals how brains immune system fights viral encephalitis
Post Your Comments:
(Date:10/6/2008)...cer before it has a chance to take root and spread...ion to new discoveries in cancer prevention. Leadi...share the latest research in this expanding and pr...gnificantly reduce cancer incidence and mortality....cientific abstracts and related activities, the pr...
(Date:10/6/2008)... researchers and collaborators have found, in a pr...contributes to one in five cases of isolated cleft...een associated with cleft lip alone, rather than b...nsight on a previously unknown genetic mechanism a...n and treatment of cleft lip, which affects more t...
(Date:10/5/2008)...in the Journal of Cell Biology how the altered b...t in tumor cells., On 2D surfaces, cells may migr...rins, which link the cell to the extracellular mat... but exactly how has been unclear. Recent work has...dom movement, while an integrin called avb3 has be...
(Date:10/5/2008)...IMMEDIATE RELEASE , New material could speed dev...ters , Researchers in Greece report design of a...t of Energy (DOE) 2010 goals for hydrogen storage ...cal hydrogen-powered vehicles. Their study on a wa... scheduled for the Oct. 8 issue of ACS, Nano Lett...
Breaking Biology News(10 mins):Study finds genetic variant plays role in cleft lip 2Study finds genetic variant plays role in cleft lip 3American Chemical Society's Weekly PressPac 2American Chemical Society's Weekly PressPac 3American Chemical Society's Weekly PressPac 4American Chemical Society's Weekly PressPac 5American Chemical Society's Weekly PressPac 6American Chemical Society's Weekly PressPac 7American Chemical Society's Weekly PressPac 8Smith 26 Nephew Wins OXINIUM 28TM 29 Approval in Japan 13277 1Smith 26 Nephew Wins OXINIUM 28TM 29 Approval in Japan 13277 2Smith 26 Nephew Wins OXINIUM 28TM 29 Approval in Japan 13277 3Shared Health Partners With State of Tennessee to Provide Electronic Health Information for Statewide Health Information Network 13275 1Shared Health Partners With State of Tennessee to Provide Electronic Health Information for Statewide Health Information Network 13275 2Brad Williams Joins OrthoSynetics 28TM 29 as Director IT Infrastructure 13273 1Brad Williams Joins OrthoSynetics 28TM 29 as Director IT Infrastructure 13273 2Live Healthier ZAP Those Germs 21 13271 1Live Healthier ZAP Those Germs 21 13271 2
...r babies her age are doing -- she,s feeding hersel...ce." , Lolita Harding is describing her daughter D... in large part to a thymus transplant she received...o reconstitute her absent immune system. Dave,yana... Duke to correct immune system deficiencies caused...
... of their work in the brain, but they also leave b...emicals that may be used in the future to direct b...atric conditions, say Duke University Medical Cent...use metabolomics -- the measurement of thousands o...sses -- to look at a psychiatric disease and its r...
...ity at Buffalo’s Research Institute on Addictions ...-- called endocannabinoid -- in the regulation of ...ive-year, $1.7 million grant from the National Ins...gation. , “It is widely accepted that one of the... is to relieve stress,?according to Samir Haj-Dahm...
...ors (dopaminergics) in brain cells has produced im...g to the results of tests carried out with monkeys...ía Rosario Luquin Piudo, neurologist at the Hospit...al centre, CIMA (the Research Centre for Applied M... latest issue of the British scientific journal sp...
Other Biology News:Thymus transplants gives hope to babies with fatal immune disease 2Thymus transplants gives hope to babies with fatal immune disease 3Chemical maps hint at drug's effects on schizophrenia 2Chemical maps hint at drug's effects on schizophrenia 3Implanting dopamine generators in brain cells obtains improvement in Parkinson's in monkeys 2Implanting dopamine generators in brain cells obtains improvement in Parkinson's in monkeys 3
(Date:10/3/2008)...Symbol: MS, EDMONTON, Oct. 3 /PRNewswire-FirstCal...loper in the treatment of multiple sclerosis (MS),...Monitoring Board (DSMB) for the,Company,s U.S. piv...8298),in patients with secondary progressive MS ha... the trial continue as per the protocol., This wa...
(Date:10/3/2008)...or Ap3ana, CTI,s ,personalized medicine, venture, ...erapeutics, Inc. (CTI),(Nasdaq: CTIC ) announced ...t recently President and COO of a Tyr Pharma and f...mics Institute of the Novartis Research,Foundation... Bresso, Italy,CTI Europe currently conducts the ...
(Date:10/2/2008)...2 /- Helix BioPharma,Corp. ... its private,placement announced on September 30, ...ss proceeds totaling CDN$11,424,000., Each unit c...mmon share,purchase warrant, with each whole commo...urchase, subject to adjustment, one common share a...
(Date:10/2/2008)...Provides Business Update to Investors, WILMINGTON...today at an,investor conference, DuPont Vice Presi...ny,s plans to bring its two advanced biofuels prog... technical progress toward the,commercialization o...stocks,economically into biofuels., "Biobutanol a...
Breaking Biology Technology:BioMS Medical's phase III U.S. multiple sclerosis trial receives positive safety review from Data Safety Monitoring Board 2Former Scientific Director at Genomics Institute of Novartis Research Foundation Named President of Cell Therapeutics Europe 2Former Scientific Director at Genomics Institute of Novartis Research Foundation Named President of Cell Therapeutics Europe 3Former Scientific Director at Genomics Institute of Novartis Research Foundation Named President of Cell Therapeutics Europe 4Helix Biopharma Closes $11.4 Million Private Placement 2DuPont Meeting Significant 2008 Milestones in Progressing Advanced Biofuels 2DuPont Meeting Significant 2008 Milestones in Progressing Advanced Biofuels 3
...throughout Europe, I can,t help making the obvious... the U.S. and in various European countries. , ,I,...n hop onto a Wi-Fi network just about anywhere, an...dth. Here in Europe, with a few exceptions, Wi-Fi ...s report from a relatively "cheap" Wi-Fi network, ...
...is opening a liason office with one or two staff m...campus. Hiroki Tanaka, vice president and general ...ratories, is responsible for seeking out opportuni.... , ,NTT and UW-Platteville began their relationsh...pan in September 2004. Now, the company is also of...
...y Network edition, we interviewed Barry Chaiken, c... is a physician and associate chief medical office...cutive, what questions should I be asking about my... Chaiken, MD Chaiken: Am I getting any value fro...els. One of them is going to be: Am I saving money...
...ology officials hope Froedtert Memorial Lutheran ...entrepreneurial medical imaging company will be th...sting. , ,In the past, the state,s early-stage bio...the hope of gaining a long-term funding commitment...ieve they are more likely to curry favor with mone...
Other Biology Technology:U.S. risks third-world status in key technology 2U.S. risks third-world status in key technology 3Interview: Dr. Barry Chaiken on healthcare IT 2Interview: Dr. Barry Chaiken on healthcare IT 3Froedtert invests $1.5M in local medical imaging startup 2Froedtert invests $1.5M in local medical imaging startup 3